LifeVantage Declares Quarterly Dividend
LifeVantage Corporation (LFVN), a health and wellness company, has announced a quarterly cash dividend of $0.045 per share of common stock. The dividend represents a 12.5% increase from the previous quarter. The dividend will be paid on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. LifeVantage specializes in products designed to activate optimal health processes at the cellular level.
LifeVantage Corporation (LFVN), un'azienda nel settore della salute e del benessere, ha annunciato un dividendo trimestrale in contanti di 0,045 $ per azione di azioni ordinarie. Il dividendo rappresenta un incremento del 12,5% rispetto al trimestre precedente. Il pagamento del dividendo avverrà il 13 giugno 2025, per gli azionisti registrati alla chiusura delle attività del 30 maggio 2025. LifeVantage è specializzata in prodotti progettati per attivare processi di salute ottimali a livello cellulare.
LifeVantage Corporation (LFVN), una empresa de salud y bienestar, ha anunciado un dividendo trimestral en efectivo de 0,045 $ por acción de acciones comunes. El dividendo representa un aumento del 12,5% con respecto al trimestre anterior. El dividendo se pagará el 13 de junio de 2025, a los accionistas registrados al cierre del negocio el 30 de mayo de 2025. LifeVantage se especializa en productos diseñados para activar procesos óptimos de salud a nivel celular.
LifeVantage Corporation (LFVN)는 건강 및 웰니스 회사로서 보통주 1주당 0.045달러의 분기 현금 배당을 발표했습니다. 이번 배당은 이전 분기 대비 12.5% 증가한 금액입니다. 배당금은 2025년 6월 13일에 지급되며, 2025년 5월 30일 영업 종료 시점에 주주명부에 등재된 주주들에게 지급됩니다. LifeVantage는 세포 수준에서 최적의 건강 프로세스를 활성화하는 제품을 전문으로 합니다.
LifeVantage Corporation (LFVN), une entreprise de santé et bien-être, a annoncé un dividende trimestriel en espèces de 0,045 $ par action d'actions ordinaires. Ce dividende représente une augmentation de 12,5 % par rapport au trimestre précédent. Le dividende sera versé le 13 juin 2025 aux actionnaires inscrits à la clôture des opérations le 30 mai 2025. LifeVantage se spécialise dans des produits conçus pour activer des processus de santé optimaux au niveau cellulaire.
LifeVantage Corporation (LFVN), ein Unternehmen im Bereich Gesundheit und Wellness, hat eine vierteljährliche Bardividende von 0,045 $ pro Aktie der Stammaktien angekündigt. Die Dividende stellt eine Steigerung von 12,5% gegenüber dem Vorquartal dar. Die Dividende wird am 13. Juni 2025 an die zum Geschäftsschluss am 30. Mai 2025 eingetragenen Aktionäre ausgezahlt. LifeVantage spezialisiert sich auf Produkte, die optimale Gesundheitsprozesse auf zellulärer Ebene aktivieren.
- 12.5% increase in quarterly dividend payment
- Demonstrates company's commitment to returning value to shareholders
- Indicates financial stability and positive cash flow
- None.
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Cautionary Note Regarding Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding expected financial performance, including revenue and margins, executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
What is LifeVantage's (LFVN) new quarterly dividend amount for 2025?
When will LifeVantage (LFVN) pay its quarterly dividend in June 2025?
By what percentage did LifeVantage increase its dividend in May 2025?
What is the record date for LifeVantage's Q2 2025 dividend?
